The role of anti-Factor-Xa monitoring in the dosing and administration of low molecular weight heparins in pregnancy: a systematic review and meta-analysis.
BACKGROUND Our aim was to determine the risk of thromboembolic complications (TECs) and major bleeding with weight-based, fixed- and anti-Xa-monitored dosing of low molecular weight heparins (LMWH) during pregnancy. METHODS We conducted a systematic review wherein we searched seven databases for articles published be...